OGN Organon & Co.
-
Organon Missed Consensus Estimates
Friday, July 31, 2026 · 12:00 AM ET
Organon (OGN) reported earnings of $0.80 per share on revenue of $1.56 billion for the second quarter ended June 2026. The consensus earnings estimate was $0.85 per share. The company missed consensus estimates by 5.88% while revenue fell 2.26% compared to the same quarter a year ago.
Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives.
Earnings Whisper Grade
—
Power Rating—
Reported Earnings
$0.80
Earnings Whisper®
—
Consensus Estimate
$0.85
Earnings Surprise
Earnings Growth
Reported Revenue
$1.56B
Revenue Estimate
—
Revenue Surprise
Revenue Growth